Veracyte is a diagnostics company offering genomic tests and software that help physicians assess cancer risk and guide treatment across thyroid, lung, prostate, and other indications.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Louis Bacon / Moore | 56 | Added +87% | 79,760 | $2,569,070 | 0.1% |
| Bridgewater | 55 | Added +223% | 91,590 | $2,950,114 | 0.0% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-03-03 | Gilbert Cisneros CA31 | BUY | $1,001 - $15,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.